Inhibition of ketohexokinase in adults with NAFLD reduces liver fat and inflammatory markers: A randomized phase 2 trial
David J. Kazierad, Kristin Chidsey, Veena Somayaji, Arthur Bergman, Morris J. Birnbaum, Roberto A. Calle
Topics & Concepts
PlaceboMedicineInternal medicineTolerabilityClinical endpointSteatosisGastroenterologyFatty liverEndocrinologyRandomizationAdverse effectInsulin resistanceRandomized controlled trialObesityPathologyDiseaseAlternative medicineLiver Disease Diagnosis and TreatmentDiet, Metabolism, and DiseaseDiet and metabolism studies